Posts by: Joana Carvalho, PhD

Joana Carvalho, PhD

Joana holds a BSc in Biology, a MSc in Evolutionary and Developmental Biology and a PhD in Biomedical Sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that made up the lining of blood vessels — found in the umbilical cord of newborns.

November 23, 2020November 23, 2020

S. Aureus Found Mostly in Lung Mucus, Not Tissue, Pig Model Shows

News

Using pig lungs as a model, scientists discovered that Staphylococcus aureus, a species of bacteria often found in the lungs of children with cystic fibrosis (CF), preferentially colonizes the mucus ... Read more

November 10, 2020November 10, 2020

Home Monitoring of Lung Health Possible With NuvoAir System, Studies Report

cystic fibrosis, News

The NuvoAir Home platform — NuvoAir’s respiratory support system for people with lung diseases — allows adults and children with cystic fibrosis (CF) to gather high quality data on ... Read more

November 9, 2020November 9, 2020

CFF Awards $2.4M to Advance CB-280 in Preventing Lung Infections

cystic fibrosis, News

The Cystic Fibrosis Foundation (CFF) has awarded up to $2.4 million to Calithera Biosciences to advance in testing CB-280, its investigative oral therapy that aiming to lower the risk of lung ... Read more

October 14, 2020October 14, 2020

Toronto Scientist Wins Award for Work Into Alternative Way of Treating CF

cystic fibrosis, News

Medicine by Design, which supports work in regenerative medicines, gave a 2020 New Ideas Awards to support a researcher exploring an alternative pathway to the CFTR protein as a ... Read more

October 5, 2020October 5, 2020

Student-Led Konglomerate Games Wins Entrepreneurship Award for CF Therapy Game

News

Konglomerate Games, the student-made company that developed a video game to encourage children with cystic fibrosis (CF) to do their breathing exercises, won first prize in the 2020 Santander ... Read more

September 24, 2020September 24, 2020

GI Problems Common and ‘Intrude’ on Daily Life, CF Survey Finds

cystic fibrosis, News

Gastrointestinal (GI) problems are common to people with cystic fibrosis (CF), especially those with pancreatic insufficiency, and can considerably disrupt daily life, an online survey by researchers in the U.K. ... Read more

August 28, 2020November 13, 2020

Trikafta’s Arrival in Canada Could Cut CF Deaths by 15% Over 10 Years, Study Suggests

cystic fibrosis, News

If Trikafta — Vertex Pharmaceuticals’ next-generation triple combination cystic fibrosis (CF) therapy — were to be available in Canada next year, the median age of CF patients could rise by 9.2 ... Read more

August 27, 2020August 27, 2020

Proteostasis Therapeutics Merges With Yumanity Therapeutics

cystic fibrosis, News

Proteostasis Therapeutics (PTI) has entered into a definitive merger agreement with Yumanity Therapeutics to leverage their common expertise about protein misfolding to advance the development of disease-modifying therapies for several ... Read more

August 21, 2020August 25, 2020

NuvoAir Home Platform Classified as Class Im Medical Device

cystic fibrosis, News

Note: This story was updated Aug. 25, 2020, to clarify that, according to NuvoAir, the regulatory entity in question is the European Medical Device Directive. The NuvoAir Home platform, ... Read more

August 20, 2020August 21, 2020

FDA Grants Orphan Drug Designation to KB407, Potential Gene Therapy for CF

cystic fibrosis, News

The U.S. Food and Drug Administration (FDA) has granted the designation of orphan drug to KB407, Krystal Biotech’s potential inhaled gene therapy for the treatment of cystic fibrosis (CF). ... Read more